{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:22:45Z","timestamp":1761765765846},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Tuberculosis is classified as either pulmonary or extra-pulmonary (EPTB). While much focus has been paid to pulmonary tuberculosis, EPTB has received scant attention. Moreover, EPTB is viewed as one wastebasket diagnosis, as \u201cthe other\u201d which is not pulmonary.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This is a retrospective cohort study of all patients treated for EPTB in the state of Texas between January 2000 and December 2005, who had no pulmonary disease. Clinical and epidemiological factors were abstracted from electronic records of the Report of Verified Case of Tuberculosis. The long-term outcome, which is death by December 2011, was established using the Social Security Administration Death Master File database. Survival in EPTB patients was compared to those with latent tuberculosis, as well as between different types of EPTB, using Cox proportional hazard models. A hybrid of the machine learning method of classification and regression tree analyses and standard regression models was used to identify high-order interactions and clinical factors predictive of long-term all-cause mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Four hundred and thirty eight patients met study criteria; the median study follow-up period for the cohort was 7.8 (inter-quartile range 6.0-10.1) years. The overall all-cause mortality rate was 0.025 (95% confidence interval [CI]: 0.021-0.030) per 100 person-year of follow-up. The significant predictors of poor long-term outcome were age (hazard ratio [HR] for each year of age-at-diagnosis was 1.05 [CI: 1.04-1.06], treatment duration, type of EPTB and HIV-infection (HR\u2009=\u20092.16; CI: 1.22, 3.83). Mortality in genitourinary tuberculosis was no different from latent tuberculosis, while meningitis had the poorest long-term outcome of 46.2%. Compared to meningitis the HR for death was 0.50 (CI: 0.27-0.91) for lymphatic disease, 0.42 (CI: 0.21-0.81) for bone\/joint disease, and 0.59 (CI: 0.27-1.31) for peritonitis. The relationship between mortality and therapy duration for each type of EPTB was a unique \u201cV\u201d shaped curve, with the lowest mortality observed at different therapy durations for each, beyond which mortality increased.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>EPTB is comprised of several different diseases with different outcomes and durations of therapy. The \u201cV\u201d shaped relationship between therapy duration and outcome leads to the hypothesis that longer duration of therapy may lead to higher patient mortality.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2334-14-115","type":"journal-article","created":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T02:18:42Z","timestamp":1393640322000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Therapy duration and long-term outcomes in extra-pulmonary tuberculosis"],"prefix":"10.1186","volume":"14","author":[{"given":"Tobias","family":"Pusch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jotam G","family":"Pasipanodya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"Ronald G","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tawanda","family":"Gumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,1]]},"reference":[{"key":"3062_CR1","volume-title":"Tuberculosis\u00a0factsheet No 104","author":"World Health Organization","year":"2011","unstructured":"World Health Organization: Tuberculosis\u00a0factsheet No 104. 2011, Geneva, Switzerland: World Health Organization"},{"key":"3062_CR2","volume-title":"TB Epidemiology and Surveillance Workshop. (Increasing\/Decreasing Over\/Under\/Diagnosis of Extrapulmonary TB)","author":"World Health Organization","year":"2005","unstructured":"World Health Organization: TB Epidemiology and Surveillance Workshop. (Increasing\/Decreasing Over\/Under\/Diagnosis of Extrapulmonary TB). 2005, Geneva, Switzerland"},{"key":"3062_CR3","doi-asserted-by":"publisher","first-page":"285","DOI":"10.4269\/ajtmh.2011.10-0630","volume":"85","author":"X Zhang","year":"2011","unstructured":"Zhang X, Andersen AB, Lillebaek T, Kamper-Jorgensen Z, Thomsen VO, Ladefoged K, Marrs CF, Zhang L, Yang Z: Effect of sex, age, and race on the clinical presentation of tuberculosis: a 15-year population-based study. Am J Trop Med Hyg. 2011, 85: 285-290. 10.4269\/ajtmh.2011.10-0630.","journal-title":"Am J Trop Med Hyg"},{"key":"3062_CR4","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.berh.2011.06.001","volume":"25","author":"F Nacci","year":"2011","unstructured":"Nacci F, Matucci-Cerinic M: Tuberculosis and other infections in the anti-tumour necrosis factor-alpha (anti-TNF-alpha) era. Best Pract Res Clin Rheumatol. 2011, 25: 375-388. 10.1016\/j.berh.2011.06.001.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3062_CR5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1164\/rccm.167.4.603","volume":"167","author":"HM Blumberg","year":"2003","unstructured":"Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, Fujiwara P, Grzemska M, Hopewell PC, Iseman MD, Jasmer RM, Koppaka V, Menzies RI, O\u2019Brien RJ, Reves RR, Reichman LB, Simone PM, Starke JR, Vernon AA: American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003, 167: 603-662.","journal-title":"Am J Respir Crit Care Med"},{"key":"3062_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/MD.0b013e3181df9070","volume":"89","author":"JE Shaw","year":"2010","unstructured":"Shaw JE, Pasipanodya JG, Gumbo T: Meningeal tuberculosis: high long-term mortality despite standard therapy. Medicine (Baltimore). 2010, 89: 189-195. 10.1097\/MD.0b013e3181df9070.","journal-title":"Medicine (Baltimore)"},{"key":"3062_CR7","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1086\/378642","volume":"188","author":"GE Thwaites","year":"2003","unstructured":"Thwaites GE, Simmons CP, Than Ha QN, Thi Hong CT, Phuong MP, Thi DN, Hoan PN, White NP, Tinh HT, Farrar JJ: Pathophysiology and prognosis in Vietnamese adults with tuberculous meningitis. J Infect Dis. 2003, 188: 1105-1115. 10.1086\/378642.","journal-title":"J Infect Dis"},{"key":"3062_CR8","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1128\/AAC.00064-11","volume":"55","author":"GE Thwaites","year":"2011","unstructured":"Thwaites GE, Bhavnani SM, Chau TT, Hammel JP, Torok ME, Van Wart SA, Mai PP, Reynolds DK, Caws M, Dung NT, Hien TT, Kulawy R, Farrar J, Ambrose PG: Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis. Antimicrob Agents Chemother. 2011, 55: 3244-3253. 10.1128\/AAC.00064-11.","journal-title":"Antimicrob Agents Chemother"},{"key":"3062_CR9","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1056\/NEJMoa040573","volume":"351","author":"GE Thwaites","year":"2004","unstructured":"Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, Nguyen TC, Nguyen QH, Nguyen TT, Nguyen NH, Nguyen TN, Nguyen NL, Nguyen HD, Vu NT, Cao HH, Tran TH, Pham PM, Nguyen TD, Stepniewska K, White NJ, Tran TH, Farrar JJ: Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004, 351: 1741-1751. 10.1056\/NEJMoa040573.","journal-title":"N Engl J Med"},{"key":"3062_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1473-3099(12)70264-5","volume":"13","author":"R Ruslami","year":"2013","unstructured":"Ruslami R, Ganiem AR, Dian S, Apriani L, Achmad TH, van der Ven AJ, Borm G, Aarnoutse RE, Van CR: Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial. Lancet Infect Dis. 2013, 13: 27-35. 10.1016\/S1473-3099(12)70264-5.","journal-title":"Lancet Infect Dis"},{"key":"3062_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.7326\/0003-4819-104-1-7","volume":"104","author":"AK Dutt","year":"1986","unstructured":"Dutt AK, Moers D, Stead WW: Short-course chemotherapy for extrapulmonary tuberculosis: nine years\u2019 experience. Ann Intern Med. 1986, 104: 7-10.7326\/0003-4819-104-1-7.","journal-title":"Ann Intern Med"},{"issue":"5","key":"3062_CR12","first-page":"485","volume":"9","author":"A Kwara","year":"2005","unstructured":"Kwara A, Roahen-Harrison S, Prystowsky E, Kissinger P, Adams R, Mathison J, Hyslop NE: Manifestations and outcome of extra-pulmonary tuberculosis: impact of human immunodeficiency virus co-infection. Int J Tuberc Lung Dis. 2005, 9 (5): 485-493.","journal-title":"Int J Tuberc Lung Dis"},{"key":"3062_CR13","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1378\/chest.06-2949","volume":"131","author":"JG Pasipanodya","year":"2007","unstructured":"Pasipanodya JG, Miller TL, Vecino M, Munguia G, Garmon R, Bae S, Drewyer G, Weis SE: Pulmonary impairment after tuberculosis. Chest. 2007, 131: 1817-1824. 10.1378\/chest.06-2949.","journal-title":"Chest"},{"key":"3062_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/1471-2458-10-259","volume":"10","author":"JG Pasipanodya","year":"2010","unstructured":"Pasipanodya JG, McNabb SJ, Hilsenrath P, Bae S, Lykens K, Vecino E, Munguia G, Miller TL, Drewyer G, Weis SE: Pulmonary impairment after tuberculosis and its contribution to TB burden. BMC Public Health. 2010, 10: 259-10.1186\/1471-2458-10-259.","journal-title":"BMC Public Health"},{"key":"3062_CR15","volume-title":"National vital statistics reports","author":"E Arias","year":"2007","unstructured":"Arias E: United States life tables, 2004. National vital statistics reports. 2007, Hyattsville, MD: National Center for Health Statistics, Volume 56, 9","edition":"9"},{"key":"3062_CR16","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S1473-3099(08)70182-8","volume":"8","author":"SM Newton","year":"2008","unstructured":"Newton SM, Brent AJ, Anderson S, Whittaker E, Kampmann B: Paediatric tuberculosis. Lancet Infect Dis. 2008, 8: 498-510. 10.1016\/S1473-3099(08)70182-8.","journal-title":"Lancet Infect Dis"},{"key":"3062_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1378\/chest.09-0394","volume":"137","author":"CR Horsburgh Jr","year":"2010","unstructured":"Horsburgh CR, Goldberg S, Bethel J, Chen S, Colson PW, Hirsch-Moverman Y, Hughes S, Shrestha-Kuwahara R, Sterling TR, Wall K, Weinfurter P: Latent TB infection treatment acceptance and completion in the United States and Canada. Chest. 2010, 137: 401-409. 10.1378\/chest.09-0394.","journal-title":"Chest"},{"key":"3062_CR18","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/aje\/kwn404","volume":"169","author":"SW Hermansen","year":"2009","unstructured":"Hermansen SW, Leitzmann MF, Schatzkin A: The impact on national death index ascertainment of limiting submissions to social security administration death master file matches in epidemiologic studies of mortality. Am J Epidemiol. 2009, 169: 901-908. 10.1093\/aje\/kwn404.","journal-title":"Am J Epidemiol"},{"key":"3062_CR19","doi-asserted-by":"publisher","first-page":"e50091","DOI":"10.1371\/journal.pone.0050091","volume":"7","author":"Y Park","year":"2012","unstructured":"Park Y, Hartge P, Moore SC, Kitahara CM, Hollenbeck AR, De Berrington GA: Body mass index and mortality in non-Hispanic black adults in the NIH-AARP diet and health study. PLoS ONE. 2012, 7: e50091-10.1371\/journal.pone.0050091.","journal-title":"PLoS ONE"},{"key":"3062_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/aje\/152.2.107","volume":"152","author":"HD Sesso","year":"2000","unstructured":"Sesso HD, Paffenbarger RS, Lee IM: Comparison of national death index and world wide web death searches. Am J Epidemiol. 2000, 152: 107-111. 10.1093\/aje\/152.2.107.","journal-title":"Am J Epidemiol"},{"key":"3062_CR21","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1093\/infdis\/jit352","volume":"208","author":"JG Pasipanodya","year":"2013","unstructured":"Pasipanodya JG, McIlleron H, Burger A, Wash PA, Smith P, Gumbo T: Serum drug concentrations predictive of pulmonary tuberculosis outcomes. J Infect Dis. 2013, 208: 1464-1473. 10.1093\/infdis\/jit352.","journal-title":"J Infect Dis"},{"key":"3062_CR22","volume-title":"2000 Annual Meeting of the Society for Academic Emergency Medicine","author":"RJ Lewis","year":"2000","unstructured":"Lewis RJ: An introduction to classification and regression tree (CART) analysis. 2000 Annual Meeting of the Society for Academic Emergency Medicine. 2000, Des Plaines, IL: Society for Academic Emergency Medicine"},{"key":"3062_CR23","volume-title":"CART: Tree-Structured Non-parametric Data Analysis","author":"D Steinberg","year":"1995","unstructured":"Steinberg D, Colla P: CART: Tree-Structured Non-parametric Data Analysis. 1995, San Diego: Salford Systems"},{"key":"3062_CR24","volume-title":"Classification and Regression Trees","author":"L Breiman","year":"1984","unstructured":"Breiman L, Friedman J, Stone CJ, Olshen RA: Classification and Regression Trees. 1984, Boca Raton: Chapman and Hall\/CRC"},{"key":"3062_CR25","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1162\/089976699300016106","volume":"11","author":"L Breiman","year":"1999","unstructured":"Breiman L: Prediction games and arcing algorithms. Neural Comput. 1999, 11: 1493-1517. 10.1162\/089976699300016106.","journal-title":"Neural Comput"},{"key":"3062_CR26","first-page":"41","volume":"24","author":"L Breiman","year":"1996","unstructured":"Breiman L: Technical note: some properties of splitting criteria. Mach Learn. 1996, 24: 41-47.","journal-title":"Mach Learn"},{"key":"3062_CR27","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1128\/AAC.02208-12","volume":"57","author":"MK Jain","year":"2013","unstructured":"Jain MK, Pasipanodya JG, Alder L, Lee WM, Gumbo T: Pegylated interferon fractal pharmacokinetics: individualized dosing for hepatitis C virus infection. Antimicrob Agents Chemother. 2013, 57: 1115-1120. 10.1128\/AAC.02208-12.","journal-title":"Antimicrob Agents Chemother"},{"key":"3062_CR28","volume-title":"The Principles and Practice of Medicine","author":"W Osler","year":"1892","unstructured":"Osler W: The Principles and Practice of Medicine. 1892, New York: Appleton, 1","edition":"1"},{"key":"3062_CR29","volume-title":"The tubercle bacillus in the pulmonary lesion of man","author":"G Canetti","year":"1955","unstructured":"Canetti G: The tubercle bacillus in the pulmonary lesion of man. 1955, New York: Springer Publishing Company"},{"key":"3062_CR30","first-page":"221","volume":"15","author":"R Koch","year":"1882","unstructured":"Koch R: Die atiologie der tuberkulose. Berliner Klinischen Wocheschrift. 1882, 15: 221-230.","journal-title":"Berliner Klinischen Wocheschrift"},{"key":"3062_CR31","first-page":"295","volume":"82","author":"G Canetti","year":"1960","unstructured":"Canetti G, Grumbach F, Grosset J: Studies of bacillary populations in experimental tuberculosis of mice treated by isoniazid. Am Rev Respir Dis. 1960, 82: 295-313.","journal-title":"Am Rev Respir Dis"},{"key":"3062_CR32","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1084\/jem.123.3.445","volume":"123","author":"RM McCune","year":"1966","unstructured":"McCune RM, Feldmann FM, Lambert HP, McDermott W: Microbial persistence: I: the capacity of tubercle bacilli to survive sterilization in mouse tissues. J Exp Med. 1966, 123: 445-468. 10.1084\/jem.123.3.445.","journal-title":"J Exp Med"},{"key":"3062_CR33","first-page":"224","volume":"67","author":"R Tompsett","year":"1954","unstructured":"Tompsett R, McCune RM, Ormond L, Deuschle K, Muschenheim C, McDermott W: The influence of pyrazinamide-isoniazid on M. tuberculosis in animals and man. Trans Assoc Am Physicians. 1954, 67: 224-231.","journal-title":"Trans Assoc Am Physicians"},{"key":"3062_CR34","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1378\/chest.76.6_Supplement.771","volume":"76","author":"DA Mitchison","year":"1979","unstructured":"Mitchison DA: Basic mechanisms of chemotherapy. Chest. 1979, 76: 771-781. 10.1378\/chest.76.6_Supplement.771.","journal-title":"Chest"},{"key":"3062_CR35","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1371\/journal.pmed.0050075","volume":"5","author":"NJ Garton","year":"2008","unstructured":"Garton NJ, Waddell SJ, Sherratt AL, Lee SM, Smith RJ, Senner C, Hinds J, Rajakumar K, Adegbola RA, Besra GS, Butcher PD, Barer MR: Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum. PLoS Med. 2008, 5: e75-10.1371\/journal.pmed.0050075.","journal-title":"PLoS Med"},{"key":"3062_CR36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1378\/chest.09-0903","volume":"137","author":"SY Eum","year":"2010","unstructured":"Eum SY, Kong JH, Hong MS, Lee YJ, Kim JH, Hwang SH, Cho SN, Via LE, Barry CE: Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest. 2010, 137: 122-128. 10.1378\/chest.09-0903.","journal-title":"Chest"},{"key":"3062_CR37","doi-asserted-by":"publisher","first-page":"e17601","DOI":"10.1371\/journal.pone.0017601","volume":"6","author":"EW Tiemersma","year":"2011","unstructured":"Tiemersma EW, van der Werf MJ, Borgdorff MW, Williams BG, Nagelkerke NJ: Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. PLoS ONE. 2011, 6: e17601-10.1371\/journal.pone.0017601.","journal-title":"PLoS ONE"},{"key":"3062_CR38","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S0022-510X(00)00440-8","volume":"181","author":"SM Katrak","year":"2000","unstructured":"Katrak SM, Shembalkar PK, Bijwe SR, Bhandarkar LD: The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection. J Neurol Sci. 2000, 181: 118-126. 10.1016\/S0022-510X(00)00440-8.","journal-title":"J Neurol Sci"},{"key":"3062_CR39","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jinf.2008.07.012","volume":"57","author":"R Shukla","year":"2008","unstructured":"Shukla R, Abbas A, Kumar P, Gupta RK, Jha S, Prasad KN: Evaluation of cerebral infarction in tuberculous meningitis by diffusion weighted imaging. J Infect. 2008, 57: 298-306. 10.1016\/j.jinf.2008.07.012.","journal-title":"J Infect"},{"key":"3062_CR40","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1128\/AAC.01533-06","volume":"51","author":"T Gumbo","year":"2007","unstructured":"Gumbo T, Louie A, Deziel MR, Liu W, Parsons LM, Salfinger M, Drusano GL: Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin. Antimicrob Agents Chemother. 2007, 51: 3781-3788. 10.1128\/AAC.01533-06.","journal-title":"Antimicrob Agents Chemother"},{"key":"3062_CR41","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1128\/AAC.00185-07","volume":"51","author":"T Gumbo","year":"2007","unstructured":"Gumbo T, Louie A, Liu W, Brown D, Ambrose PG, Bhavnani SM, Drusano GL: Isoniazid bactericidal activity and resistance emergence: integrating pharmacodynamics and pharmacogenomics to predict efficacy in different ethnic populations. Antimicrob Agents Chemother. 2007, 51: 2329-2336. 10.1128\/AAC.00185-07.","journal-title":"Antimicrob Agents Chemother"},{"key":"3062_CR42","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1128\/AAC.01681-08","volume":"53","author":"T Gumbo","year":"2009","unstructured":"Gumbo T, Siyambalapitiyage Dona CS, Meek C, Leff R: Pharmacokinetics-pharmacodynamics of pyrazinamide in a novel in vitro model of tuberculosis for sterilizing effect: a paradigm for faster assessment of new antituberculosis drugs. Antimicrob Agents Chemother. 2009, 53: 3197-3204. 10.1128\/AAC.01681-08.","journal-title":"Antimicrob Agents Chemother"},{"key":"3062_CR43","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1086\/651377","volume":"201","author":"S Srivastava","year":"2010","unstructured":"Srivastava S, Musuka S, Sherman C, Meek C, Leff R, Gumbo T: Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol. J Infect Dis. 2010, 201: 1225-1231. 10.1086\/651377.","journal-title":"J Infect Dis"},{"key":"3062_CR44","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/cid\/cis353","volume":"55","author":"JG Pasipanodya","year":"2012","unstructured":"Pasipanodya JG, Srivastava S, Gumbo T: Meta-analysis of clinical studies supports the pharmacokinetic variability hypothesis for acquired drug resistance and failure of antituberculosis therapy. Clin Infect Dis. 2012, 55: 169-177. 10.1093\/cid\/cis353.","journal-title":"Clin Infect Dis"},{"key":"3062_CR45","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1128\/AAC.00763-10","volume":"55","author":"PM Jeena","year":"2011","unstructured":"Jeena PM, Bishai WR, Pasipanodya JG, Gumbo T: In silico children and the glass mouse model: clinical trial simulations to identify and individualize optimal isoniazid doses in children with tuberculosis. Antimicrob Agents Chemother. 2011, 55: 539-545. 10.1128\/AAC.00763-10.","journal-title":"Antimicrob Agents Chemother"},{"key":"3062_CR46","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.tube.2010.07.002","volume":"90","author":"PR Donald","year":"2010","unstructured":"Donald PR: Cerebrospinal fluid concentrations of antituberculosis agents in adults and children. Tuberculosis (Edinb). 2010, 90: 279-292. 10.1016\/j.tube.2010.07.002.","journal-title":"Tuberculosis (Edinb)"},{"key":"3062_CR47","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1007\/s00586-008-0778-7","volume":"17","author":"Z Ge","year":"2008","unstructured":"Ge Z, Wang Z, Wei M: Measurement of the concentration of three antituberculosis drugs in the focus of spinal tuberculosis. Eur Spine J. 2008, 17: 1482-1487. 10.1007\/s00586-008-0778-7.","journal-title":"Eur Spine J"},{"key":"3062_CR48","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1093\/infdis\/jir658","volume":"204","author":"S Srivastava","year":"2011","unstructured":"Srivastava S, Pasipanodya JG, Meek C, Leff R, Gumbo T: Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability. J Infect Dis. 2011, 204: 1951-1959. 10.1093\/infdis\/jir658.","journal-title":"J Infect Dis"},{"key":"3062_CR49","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1128\/JCM.02180-07","volume":"46","author":"G Thwaites","year":"2008","unstructured":"Thwaites G, Caws M, Chau TT, D\u2019Sa A, Lan NT, Huyen MN, Gagneux S, Anh PT, Tho DQ, Torok E, Nhu NT, Duyen NT, Duy PM, Richenberg J, Simmons C, Hien TT, Farrar J: Relationship between Mycobacterium tuberculosis genotype and the clinical phenotype of pulmonary and meningeal tuberculosis. J Clin Microbiol. 2008, 46: 1363-1368. 10.1128\/JCM.02180-07.","journal-title":"J Clin Microbiol"},{"key":"3062_CR50","doi-asserted-by":"publisher","first-page":"e1000034","DOI":"10.1371\/journal.ppat.1000034","volume":"4","author":"M Caws","year":"2008","unstructured":"Caws M, Thwaites G, Dunstan S, Hawn TR, Lan NT, Thuong NT, Stepniewska K, Huyen MN, Bang ND, Loc TH, Gagneux S, Van SD, Kremer K, Van der SM, Small P, Anh PT, Chinh NT, Quy HT, Duyen NT, Tho DQ, Hieu NT, Torok E, Hien TT, Dung NH, Nhu NT, Duy PM, Van Vinh CN, Farrar J: The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog. 2008, 4: e1000034-10.1371\/journal.ppat.1000034.","journal-title":"PLoS Pathog"},{"key":"3062_CR51","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.1128\/JCM.01181-06","volume":"44","author":"M Caws","year":"2006","unstructured":"Caws M, Thwaites G, Stepniewska K, Nguyen TN, Nguyen TH, Nguyen TP, Mai NT, Phan MD, Tran HL, Tran TH, Van SD, Kremer K, Nguyen VV, Nguyen TC, Farrar J: Beijing genotype of Mycobacterium tuberculosis is significantly associated with human immunodeficiency virus infection and multidrug resistance in cases of tuberculous meningitis. J Clin Microbiol. 2006, 44: 3934-3939. 10.1128\/JCM.01181-06.","journal-title":"J Clin Microbiol"},{"key":"3062_CR52","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/ng.2656","volume":"45","author":"CB Ford","year":"2013","unstructured":"Ford CB, Shah RR, Maeda MK, Gagneux S, Murray MB, Cohen T, Johnston JC, Gardy J, Lipsitch M, Fortune SM: Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis. Nat Genet. 2013, 45: 784-790. 10.1038\/ng.2656.","journal-title":"Nat Genet"},{"key":"3062_CR53","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1093\/jac\/dks277","volume":"67","author":"S Esposito","year":"2012","unstructured":"Esposito S, Esposito I, Leone S: Considerations of antibiotic therapy duration in community-and hospital-acquired bacterial infections. J Antimicrob Chemother. 2012, 67: 2570-2575. 10.1093\/jac\/dks277.","journal-title":"J Antimicrob Chemother"},{"key":"3062_CR54","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L: Random forests. Mach Learn. 2001, 45: 5-32. 10.1023\/A:1010933404324.","journal-title":"Mach Learn"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-14-115\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:05:26Z","timestamp":1630551926000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-14-115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3062"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-14-115","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,1]]},"assertion":[{"value":"8 August 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"115"}}